News
Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter
03-Aug-2026 | 16:39
Sales rise 16.55% to Rs 938.44 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 938.44 | 805.17 | 17 |
| OPM % | 31.49 | 31.20 | - |
| PBDT | 338.29 | 294.50 | 15 |
| PBT | 322.45 | 278.98 | 16 |
| NP | 237.18 | 205.01 | 16 |
Powered by Capital Market - Live News